KLK3 and pachyonychia congenita: It has been proved to reduce the detection of low-risk PC cases significantly when performed prior to prostate biopsy in men with elevated PSA levels, thus mitigating the risks of overdiagnosis and the adverse effects of PC screening [21], [22].